课题基金 / 基金详情

项目摘要

项目成果

ROBERT M GRAHAM的其他基金

相似基金

相关文献

中文摘要
翻译
心房利钠因子(ANF)是最近发现的一种储存在
英文摘要
Atrial natriuretic factor (ANF) is a recently discovered peptide stored in specific granules within the atrial myocyte that has potent natriuretic and vasorelaxant properties. Although considerable progress has been made in elucidating its primary structure and in isolating and characterizing its gene, the significance of ANF as a humoral factor in maintaining cardiovascular homeostasis, particularly in relation to volume and blood pressure control, is virtually unknown. It is the major aim of this proposal to define this role. The approach is multidisciplinary and will utilize methods from the fields of molecular biology, immunochemistry and phsyiology. Transcriptional and translational control mechanisms will be investigated utilizing CDNA probes and immunoprecipitation procedures to quantitate ANF production in cultured atrial cardiocytes in response to specific stimuli. Immunochemical techniques will be developed to measure ANF levels in plasma and to determine the structure of the stored, secreted and circulating forms. Intact animal studies, in particular the conscious instrumented dog, will allow us to relate changes in ANF synthesis (i.e. transcriptional and translational regulation) and release to specific physiological manipulations, including the development of perinephritic hypertension, as well as to define the neural, vascular and humoral factors that regulate these processes. Similarly, stu7dies in humans will be initiated to define the role of ANF in maintaining volume and pressure homeostasis. These studies will also form the basis for identifying potential diseases that ;may represent abnormalities in the genetic regulation of ANF production. In particular, the method of restriction fragment length analysis to define polymorphisms in the ANF gene or in its vicinity will be utilized to identify potential linkage with particular disease states where such an abnormality might be predicted, such as Bartter's and Gordon's syndromes. These techniques will also be extended to test the hypothesis that a genetic abnormality in ANF expression may be involved in the etiology of certain forms of hypertension.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Ouabain induces secretion of proatrial natriuretic factor by rat atrial cardiocytes.
哇巴因诱导大鼠心房心肌细胞分泌心房钠尿因子。
DOI: 10.1152/ajpendo.1988.255.3.e383
发表时间: 1988
期刊: The American journal of physiology
影响因子: --
作者: [Bloch,KD, Zamir,N, Lichtstein,D, Seidman,CE, Seidman,JG]
通讯作者: Seidman,JG
cis-dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic mice.
转基因小鼠中大鼠心房钠尿因子基因调控序列的顺式显性。
DOI: 10.1139/y91-223
发表时间: 1991
期刊: Canadian journal of physiology and pharmacology
影响因子: 2.1
作者: [Seidman,CE, Schmidt,EV, Seidman,JG]
通讯作者: Seidman,JG
Analysis of atrial natriuretic factor biosynthesis and secretion in adult and neonatal rat atrial cardiocytes.
成年和新生大鼠心房心肌细胞心房钠尿因子生物合成和分泌的分析。
DOI: 10.1016/0024-3205(87)90748-x
发表时间: 1987
期刊: Life sciences
影响因子: 6.1
作者: [Zisfein,JB, Sylvestre,D, Homcy,CJ, Graham,RM]
通讯作者: Graham,RM
Characterization and purification of a protease in serum that cleaves proatrial natriuretic factor (ProANF) to its circulating forms.
血清中一种蛋白酶的表征和纯化,该蛋白酶可将心房钠尿因子 (ProANF) 裂解为其循环形式。
DOI: 10.1021/bi00400a030
发表时间: 1987
期刊: Biochemistry
影响因子: 2.9
作者: [Zisfein,JB, Graham,RM, Dreskin,SV, Wildey,GM, Fischman,AJ, Homcy,CJ]
通讯作者: Homcy,CJ
7
    SCOR IN HYPERTENSION
    • 批准号:
      3106707
    • 项目类别:
    • 资助金额:
      $69.06万
    • 财政年份:
      1990
    • 负责人:
      ROBERT M GRAHAM
    • 依托单位:
    SCOR IN HYPERTENSION
    • 批准号:
      3106708
    • 项目类别:
    • 资助金额:
      $68.17万
    • 财政年份:
      1990
    • 负责人:
      ROBERT M GRAHAM
    • 依托单位:
    ALPHA-RECPTOR PURIFICATION & ROLE IN NEUROTRANSMISSION
    • 批准号:
      3399686
    • 项目类别:
    • 资助金额:
      $16.57万
    • 财政年份:
      1989
    • 负责人:
      ROBERT M GRAHAM
    • 依托单位:
    ALPHA-RECPTOR PURIFICATION & ROLE IN NEUROTRANSMISSION
    • 批准号:
      3399691
    • 项目类别:
    • 资助金额:
      $17.98万
    • 财政年份:
      1989
    • 负责人:
      ROBERT M GRAHAM
    • 依托单位:
    海外基金